BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
65.66
+0.66 (1.02%)
Dec 20, 2024, 4:00 PM EST - Market closed
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$94.20
Upside
+43.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +37.07% | Dec 12, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $95 | Buy | Initiates | $95 | +44.68% | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Maintains $93 → $81 | Hold | Maintains | $93 → $81 | +23.36% | Oct 30, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $93 → $84 | Hold | Maintains | $93 → $84 | +27.93% | Oct 30, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $110 → $90 | Buy | Maintains | $110 → $90 | +37.07% | Oct 30, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $110 → $109 | Buy | Maintains | $110 → $109 | +66.01% | Oct 30, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +21.84% | Oct 30, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +59.91% | Oct 30, 2024 |
| UBS | UBS | Strong Buy Maintains $104 → $106 | Strong Buy | Maintains | $104 → $106 | +61.44% | Oct 30, 2024 |
| Baird | Baird | Hold Maintains $72 → $65 | Hold | Maintains | $72 → $65 | -1.01% | Oct 30, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2024 |
| Raymond James | Raymond James | Buy Initiates $79 | Buy | Initiates | $79 | +20.32% | Oct 10, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $85 → $80 | Hold | Maintains | $85 → $80 | +21.84% | Oct 4, 2024 |
| Barclays | Barclays | Buy Maintains $110 → $86 | Buy | Maintains | $110 → $86 | +30.98% | Oct 4, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $95 → $78 | Hold | Maintains | $95 → $78 | +18.79% | Sep 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $118 → $90 | Strong Buy | Maintains | $118 → $90 | +37.07% | Sep 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.